Clinical Trials Sponsored by Lightpoint Medical Limited

Total 200 results

Lightpoint Medical Limited

Unknown

Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer (LPM-012)

Prostate Cancer

Spain, Belgium, France, Germany
Lightpoint Medical Limited

Not yet recruiting

The LightPath® and 68Ga-RM2 in Breast Cancer Study

Breast Cancer

United Kingdom
Lightpoint Medical Limited
Semmelweis University

Withdrawn

Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery (CLIO)

Gastric Cancer | Pancreatic Cancer | Bile Duct Cancer | Duodenal Cancer

Hungary
Lightpoint Medical Limited
European Commission

Unknown

The LightPath® Breast Cancer Study

Breast Cancer

Poland, United Kingdom
Lightpoint Medical Limited
University College London Hospitals; University College, London

Completed

PRIME - PRostate Imaging for Margin Evaluation (PRIME)

Prostatic Neoplasms

United Kingdom
Lightpoint Medical Limited
King's College London; Guy's and St Thomas' NHS Foundation Trust

Unknown

The Breast Surgery EnLight and LightPath Imaging System Study

Breast Neoplasms

United Kingdom
Lightpoint Medical Limited
King's College London; Guy's and St Thomas' NHS Foundation Trust

Completed

LightPathTM Imaging System for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical Specimens

Breast Cancer

United Kingdom
Bluedrop Medical Limited

Recruiting

Remote Monitoring of the Diabetic Foot to Prevent Re-Ulceration (MASTER)

Diabetic Foot

United States
Bluedrop Medical Limited

Completed

Use of Remote Thermovisual Monitoring in Patients With a Previous Diabetic Foot Ulcer

Diabetic Foot Ulcer

United Kingdom, Ireland
Vivasure Medical Limited

Completed

PerQseal® Impella Early Feasibility Study

Percutaneous Large Hole Vascular Closure

United States
Synaptic Medical Limited

Unknown

Renal Denervation With Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension

Primary Hypertension

China
Vivasure Medical Limited

Completed

Safety and Performance Study of Large Hole Vascular Closure Device (FRONTIER-II)

Percutaneous Common Femoral Artery Arteriotomy Closure

Germany, United Kingdom, Ireland, Belgium
Vivasure Medical Limited

Completed

Safety and Performance Study of Large Hole Vascular Closure Device (Frontier-III)

18 to 24 F Percutaneous Femoral Arteriotomy Closure

Germany
Vivasure Medical Limited

Not yet recruiting

Safety and Performance Study for Arterial Large Hole Vascular Closure Device (ELITE)

Large Hole Percutaneous Arterial Closure
Vivasure Medical Limited

Recruiting

PerQseal® Clinical Study

Percutaneous Large Hole Vascular Closure

United States, Germany
Vivasure Medical Limited

Not yet recruiting

Safety and Performance Study of Large Hole Vascular Closure Device - France (FRONTIER V)

Large Hole Percutaneous Arterial Closure
Vivasure Medical Limited

Recruiting

Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study

Percutaneous Arteriotomy Closure

Germany, Netherlands
Vivasure Medical Limited

Completed

PerQseal®+ Early Feasibility Study

Percutaneous Large Hole Vascular Closure

United States
Vivasure Medical Limited

Completed

Safety and Performance Study of Large Hole Vascular Closure Device FIV (Frontier-IV)

Percutaneous CFA Arteriotomy Closure

Ireland, Germany
OncoSil Medical Limited

Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel. (OncoPaC-1)

Unresectable Locally Advanced Pancreatic Carcinoma

United States
Vivasure Medical Limited

Completed

Safety and Performance Study of Large Hole Vascular Closure Device (FRONTIER-I)

Percutaneous Closure of Arteriotomy in Common Femoral Artery

Ireland
Vivasure Medical Limited

Not yet recruiting

PerQseal® Elite Venous Clinical Study (ELITE-Venous) (ELITE-Venous)

Large Hole Percutaneous Venous Closure
Capri Medical Limited

Not yet recruiting

Minimally Invasive Electrical Stimulation Of The Nerve Hypoglossal for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea

Colombia
OncoSil Medical Limited

Recruiting

FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma (TRIPP-FFX)

Locally Advanced Pancreatic Cancer

Spain, Belgium, United Kingdom, Italy, Australia
OncoSil Medical Limited

Recruiting

OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. (OSPREY)

Neoplasms | Neoplasms by Site | Endocrine System Diseases | Pancreatic Diseases | Digestive System Neoplasm | Digestive System Disease | Pancreatic Neoplasm | Endocrine Gland Neoplasm

Spain, United Kingdom
OncoSil Medical Limited

Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane (PanCO)

Unresectable Locally Advanced Pancreatic Carcinoma

United Kingdom, Belgium, Australia
Creo Medical Limited

Unknown

Clinical Evaluation of the Safety and Performance of Microwave Coagulation Using the HS1 Instrument

Actual or Potential Nonvariceal Bleeding in the Upper Gastrointestinal (GI) Tract

United Kingdom
Creo Medical Limited
Avania

Recruiting

Bronchoscopic Microwave Ablation of Lung Tissue (AB1MALT)

Lung Cancer

United Kingdom
Sahajanand Medical Technologies Limited

Recruiting

S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System

Coronary Artery Disease

Netherlands
Asalus Medical Instruments Limited

Completed

Assessment of a New Surgical Smoke Clearing Technology in Laparoscopic Cholecystectomy (Innervision)

Focus: Surgical Smoke During Laparoscopic Surgery

United Kingdom
Haoma Medica Limited
Parexel

Unknown

Study of NaQuinate in Healthy Volunteers

Osteoporosis

United Kingdom
Humanity & Health Medical Group Limited

Completed

Antibody Response to COVID-19 Vaccines in Liver Disease Patients

Chronic Liver Disease

Hong Kong
Humanity & Health Medical Group Limited

Withdrawn

A Study to Evaluate Vaccines Against COVID-19 in the Real World

Chronic Liver Disease | Hepatic Carcinoma

Hong Kong
Boston Medical Center
Gunze Limited

Withdrawn

Pneumostasis With Use of Bio-absorbable Mesh and Fibrin Sealant in Lung Resection

Air Leak From Lung

United States
Humanity & Health Medical Group Limited

Withdrawn

Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection

HCV Infection

Hong Kong
MTI Medical Private Limited, Pakistan

Unknown

To Study the Efficacy and Safety of Renessans in Chronic HCV Patients

Hepatitis C, Chronic

Pakistan
Humanity & Health Medical Group Limited

Recruiting

Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC

Hepatocellular Carcinoma

Hong Kong
Humanity & Health Medical Group Limited

Recruiting

Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)

Chronic Hepatitis B

Hong Kong
Humanity & Health Medical Group Limited

Completed

Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura

Immune Thrombocytopenia

Hong Kong
MediSieve Limited
Radboud University Medical Center

Completed

Clinical Investigation of the Safety of the MediSieve Magnetic Haemofiltration System in Healthy Volunteers

Haemofiltration

Netherlands
The Lowy Medical Research Institute Limited

Active, not recruiting

MacTel Laser Study

Macular Telangiectasia

United States
Lee's Pharmaceutical Limited
Nanjing Medical University

Completed

A Clinical Study on Efficacy & Safety Profile of Propionyl-L-carnitine Tablets for Peripheral Arterial Diseases (PLC)

Peripheral Arterial Disease

China
The Lowy Medical Research Institute Limited

Unknown

MPOD in Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin (MacTEL-Supp)

Macular Pigment | Macular Teleangiectasia

Germany
The Lowy Medical Research Institute Limited

Active, not recruiting

Serine and Fenofibrate Study in Patients With MacTel Type 2 (SAFE)

Macular Telangiectasia Type 2

United States, United Kingdom
Collaborative Medicinal Development Pty Limited

Active, not recruiting

ALS Treatment Extension Study

Amyotrophic Lateral Sclerosis

Australia
Collaborative Medicinal Development Pty Limited

Completed

Dose Escalation Study of Cu(II)ATSM in Parkinson's Disease

Parkinson Disease

Australia
Collaborative Medicinal Development Pty Limited

Completed

Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors

Neoplasms

Australia
Collaborative Medicinal Development Pty Limited

Unknown

CuATSM Compared With Placebo for Treatment of ALS/MND

Amyotrophic Lateral Sclerosis

Australia
Collaborative Medicinal Development Pty Limited

Completed

Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001

Amyotrophic Lateral Sclerosis

Australia
Collaborative Medicinal Development Pty Limited

Completed

Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

Australia

Clinical Trials Sponsored by Lightpoint Medical Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations